Global News

NIH’s All of Us Research Program, NLM collaborate on outreach efforts through libraries

Monday, December 11, 2017

NIH’s All of Us Research Program and the National Library of Medicine (NLM) have teamed up in a landmark effort to advance precision medicine for the benefit of communities through local libraries. Traditional healthcare takes a “one-size fits all” approach, but precision medicine is healthcare that is “tailored to a person based on things unique to that individual, such as their lifestyle, environment and their biology,” said Dara Richardson-Heron, M.D., chief engagement officer, NIH’s All of Us Research Program. 

[Read More]

Health disparities and clinical trial patient recruitment

Monday, December 11, 2017

The Pulse on Patient Recruitment by Ashley Tointon

Despite remarkable improvements in the number of people with healthcare coverage and the vast improvements in many healthcare technologies, not everyone in the nation has benefited equally. Individuals who are low-income, a racial/ethnic minority or who are disadvantaged or disabled typically do not get involved in cutting-edge medical research. 

[Read More]

Bioclinica launches Clinical Adjudication for enhanced trials safety and efficacy

Friday, December 8, 2017

Bioclinica, a provider of technology-enabled solutions for clinical research, launched Bioclinica Clinical Adjudication, a transformational offering in which medical specialists and researchers, backed by advanced technology, lead independent Clinical Event Committee (CEC) review. The new service enables the independent adjudication of clinical events in conformance with regulatory requirements governing clinical trials within all therapeutic areas, including cardiac studies and for Major Adverse Cardiac Events (MACE) committees.

[Read More]

Bioclinica appoints David Herron as Chief Executive Officer

Friday, December 8, 2017

Bioclinica, a provider of specialty clinical trial services, has appointed David Herron as the company’s next Chief Executive Officer, effective January 2, 2018. This follows the planned retirement of current Chief Executive Officer, John Hubbard, PhD, who will remain as a non-Executive Director on the Bioclinica Board.

[Read More]

Johnson & Johnson and partners launch Mosaic HIV-1 Preventive Vaccine

Friday, December 8, 2017

Johnson & Johnson announced that its Janssen Pharmaceutical Companies, together with a consortium of global partners, have initiated the first efficacy study for an investigational mosaic HIV-1 preventive vaccine. The Bill & Melinda Gates Foundation and National Institutes of Health are joining forces with Johnson & Johnson to advance the potential prevention option, which is designed to be a “global vaccine” that could prevent a wide range of viral strains responsible for the HIV pandemic.

[Read More]

Certara introduces new investigator awards program in Australia

Friday, December 8, 2017

Certara, a global provider in model-informed drug development and regulatory science, announced that Leigh Farrell, Ph.D., Vice President of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). The presentation will take place today at the Australasian Pharmaceutical Science Association (APSA) and ASCEPT Joint Scientific Meeting at the Brisbane Convention & Exhibition Centre. These new Certara awards recognize graduate investigators that are excelling in clinical and experimental pharmacology and toxicology.

[Read More]